blog
AVMA working group helps navigate opioid abuse epidemic
An AVMA working group has taken up the task of providing needed information to help veterinary professionals contribute productively to the national…
blog
DEA provides update on opioid shortage
The U.S. Drug Enforcement Administration (DEA) released a statement last week on the ongoing opioid shortages affecting both human and veterinary…
blog
Farm bill delivers victory for veterinary medicine
The nation’s new farm bill creates critical programs to improve animal health and enhance the nation’s ability to prevent and respond to animal…
blog
Opioid manufacturing quotas could limit access in 2020
Veterinary access to five Schedule II opioids could be reduced next year under a proposal by the U.S. Drug Enforcement Administration (DEA) to limit…
blog
Policies up for review: Your input needed
AVMA policy is powered by AVMA members. The review process for eight policies is starting, and the volunteer groups that conduct the review are…
blog
Get answers: Frequently asked questions about COVID-19
We’ve added two new resources to our COVID-19 webpage: FAQs for veterinarians and veterinary clinics, and for pet owners.
blog
Explore cannabis topics in depth with experts
AVMA's first-ever symposium on veterinary cannabis will provide a 360-degree perspective, presented directly by key leaders in research, practice and…
blog
Report identifies antimicrobial-resistant pathogens impacting animal health
A new report on antimicrobial-resistant pathogens and their impact on animal health is now available for AVMA members to download.
blog
AVMA prepares response to FDA draft compounding guidance
Based on feedback from member veterinarians and other stakeholders, the AVMA has compiled a list of key points to share with the FDA in our formal…
blog
Antimicrobial resistance: Slowing and limiting its emergence and spread
As a practice owner, I have been struck by the number of antimicrobial-resistant bacterial infections my team and I have seen in our patients.
blog
Kudos! Veterinary researchers chosen to receive grants
Three veterinary researchers have been named recipients of research grants awarded by the American Veterinary Medical Foundation in partnership with…
blog
Pentobarbital back orders and potential alternatives
AVMA has received reports of short-term back orders of pentobarbital. While avenues to resolve are being explored, here are possible alternatives for…
blog
New FDA guidance addresses medically important antimicrobials
The U.S. Food and Drug Administration (FDA) has released new guidance to facilitate veterinary oversight of all animal antimicrobial drugs considered…
blog
Amoxicillin: Will a human drug shortage affect veterinarians?
A shortage of some amoxicillin products used in human medicine could affect veterinarians who use the drugs in an extra-label manner. No shortage of…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…